Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bone loss. Factors that regulate osteoclast differentiation: an update.

S Roux1, P Orcel

  • 1INSERM U349, Lariboisière Hospital, Paris, France.

Arthritis Research
|November 30, 2000
PubMed
Summary

Osteoclast activation drives bone loss in diseases like rheumatoid arthritis. Blocking the RANKL-RANK interaction with osteoprotegerin may offer new therapeutic strategies for bone resorption disorders.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Single nucleotide variants drive evolutionary phage-host arms race in anaerobic carbon dioxide-converting microbiome.

Nature communications·2026
Same author

Charge State Tuning of Spin Defects in Hexagonal Boron Nitride.

Nano letters·2025
Same author

Cytotoxic Effects of <i>Lecaniodiscus Cupanioides</i> (Planch.) Extract and Triterpenoids-derived Gold Nanoparticles On MCF-7 Breast Cancer Cell Lines.

Anti-cancer agents in medicinal chemistry·2025
Same author

Characterisation and hierarchy of the spermatogonial stem cell compartment in human spermatogenesis by spectral cytometry using a 16-colors panel.

Cellular and molecular life sciences : CMLS·2024
Same author

Unravelling caramelization and Maillard reactions in glucose and glucose + leucine model cakes: Formation and degradation kinetics of volatile markers extracted during baking.

Food research international (Ottawa, Ont.)·2024
Same author

ANTIFON-CLIC®, a new clinical decision support system for the treatment of invasive aspergillosis: is it clinically relevant?

Annales pharmaceutiques francaises·2023

Area of Science:

  • Bone biology and immunology
  • Cellular signaling pathways
  • Rheumatology and metabolic bone disease

Background:

  • Osteoclast activation is key in pathological bone resorption, seen in rheumatoid arthritis (RA) and generalized bone loss.
  • Cytokines like IL-1 and tumor necrosis factor-alpha (TNF-alpha) significantly contribute to excessive osteoclast activity.
  • The discovery of receptor activator of nuclear factor-kappa B (RANK) and its ligand (RANKL) highlighted their essential role in osteoclast differentiation.

Purpose of the Study:

  • To explore the role of the RANK-RANKL pathway in osteoclast differentiation.
  • To investigate the therapeutic potential of blocking the RANK-RANKL interaction.
  • To understand the mechanisms behind pathological bone resorption.

Main Methods:

Related Experiment Videos

  • Review of current literature on osteoclast biology and signaling pathways.
  • Analysis of the RANK-RANKL interaction mechanism.
  • Evaluation of osteoprotegerin as a potential therapeutic agent.

    • Main Results:

    • The interaction between RANK and RANKL is mandatory for osteoclast differentiation from hematopoietic precursors.
    • Osteoprotegerin, a decoy receptor, effectively blocks the RANK-RANKL interaction.
    • Blocking this interaction leads to decreased osteoclast activity.

    Conclusions:

    • The RANK-RANKL pathway is a critical target for controlling osteoclast activity.
    • Osteoprotegerin demonstrates significant therapeutic potential for conditions involving excessive bone resorption.
    • Targeting this pathway offers a promising approach for managing bone loss diseases.